Publications

Back to Publications

Stay up to date with our literature reviews which are curated by experts to feature the most important publications released each month. Explore our publications for access to concise summary slides for your own use.

Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age

J Am Coll Cardiol 2022;80(1):1-18 doi: 10.1016/j.jacc.2022.04.040

In this analysis from EMPEROR-Preserved, empagliflozin delivered efficacy across all age groups, with similar effects seen in older patients with heart failure with preserved ejection fraction (HFpEF).


LinkedIn